FDA Working Aggressively On Globalization Strategy – Commissioner
This article was originally published in The Rose Sheet
Executive Summary
Less than a week after the agency’s international regulatory “aggressiveness” was called into question at a Senate appropriations hearing, FDA releases its Global Engagement report, highlighting its accomplishments to date while noting that ensuring the safety of imported products is a “formidable task.”